Dubai Health Authority

Ceapro Inc. Reports 2023 Second Quarter and Six-Month Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, August 29, 2023
The Angiogenesis Foundation, Senior, Litre, Urine, Symrise, Clinical trial, MBA, Coenzyme Q10, Regulation and licensure in engineering, Trial of the century, YBG, Special Operations Executive, Regeneration, American Thoracic Society, McMaster University, Blood, Pharmacy, Growth, AVS, Dubai Health Authority, CZO, Safety, Wound healing, Pharmaceutical industry, Management, Dietary supplement, Medical device, Ready-mix concrete, Fine chemical, Cryptocurrency

EDMONTON, Alberta, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced financial results and operational highlights for the second quarter and six months ended June 30, 2023.

Key Points: 
  • Further, over the past quarter we remained very active with our activities related to strategic corporate initiatives.
  • Stability studies are ongoing for the 30mg and 240mg pills formulation manufactured, packaged and labeled by Corealis Inc. GMP Manufacturing Services.
  • Studies showed statistically significant results characterizing the bioactivity of both Ceapro’s oat-derived bioactive products on wound healing and tissue regeneration.
  • Financial Highlights for the Second Quarter and the Six-Month Period Ended June 30, 2022
    Sales of $1,869,000 for the second quarter of 2023 and $5,364,000 for the first six months of 2023 compared to $5,500,000 and $11,672,000 for the comparative periods in 2022.

Governments and Enterprises in the Middle East Join Forces to Drive AI Innovation at World AI Show

Retrieved on: 
Thursday, May 18, 2023
Jumeirah Emirates Towers Hotel, Dubai Health Authority, Ministry of Energy Infrastructures and Natural Resources (Armenia), Data management, Private, Senior advisor, Microsoft, Energy, Information technology, Research, Oil, USD, Government, Ministry, Labor federation competition in the United States, Ethics, Artificial intelligence, Communication, Growth, Environment, MENA, Statistical Center of Iran, Medical device, Drug, AI, Woman

The event will bring together Investors, global AI leaders, government officials, and industry experts to explore the latest trends, applications, and solutions in AI.

Key Points: 
  • The event will bring together Investors, global AI leaders, government officials, and industry experts to explore the latest trends, applications, and solutions in AI.
  • Meanwhile, the AI race between tech giants like Microsoft and Google is intensifying with increased investment in AI research and development.
  • Dubai's government is promoting the adoption of AI technologies as part of its strategic vision to become a global innovation and technology leader.
  • Additionally, World AI Show will be hosting the World AI Awards, recognizing the most innovative and impactful AI solutions and implementations across various industries.

Petal Ads Demonstrates its diverse Targeting Capabilities at the Arabian Travel Market 2023

Retrieved on: 
Thursday, May 4, 2023
Omni, Smart TV, Communication, Travel, Tourism, Education, DHA, Marketing, Smartphone, Dubai Health Authority, Journey, Connected, CTV, OTT, TBD, Privacy, Arabian Travel Market, Tablet, HUAWEI, DMP, Operation (mathematics), Work, Petal, Advertising, Commerce, Omnichannel, Machine learning, Transport, Health, IOT, Medical tourism, Mobile phone, Retail, Huawei, AI

DUBAI, UAE, May 4, 2023 /PRNewswire/ -- Petal Ads, a leading advertising platform by Huawei, is participating in the 30th edition of Arabian Travel Market. The leading global event for the inbound and outbound travel industry in the Middle East will take place in Dubai on 1 to 4 May. Huawei's team of experts will demonstrate the unparalleled capabilities of Petal Ads, particularly in effectively targeting the rapidly growing outbound travel markets of China and Russia.

Key Points: 
  • DUBAI, UAE, May 4, 2023 /PRNewswire/ -- Petal Ads, a leading advertising platform by Huawei, is participating in the 30th edition of Arabian Travel Market.
  • Huawei's team of experts will demonstrate the unparalleled capabilities of Petal Ads, particularly in effectively targeting the rapidly growing outbound travel markets of China and Russia.
  • Also, with targeting and privacy, Marketers can feel sure that their ad spendings on targeting will deliver excellent dividends to them.
  • Visitors of the Arabian Travel Market, businesses and executives in the travel industry, as well as marketers, will have the unique opportunity to experience Petal Ads' sophisticated targeting capabilities firsthand, designed to unlock business potential.

Petal Ads Demonstrates its diverse Targeting Capabilities at the Arabian Travel Market 2023

Retrieved on: 
Thursday, May 4, 2023
Omni, Smart TV, Communication, Travel, Tourism, Education, DHA, Marketing, Smartphone, Dubai Health Authority, Journey, Connected, CTV, OTT, TBD, Privacy, Arabian Travel Market, Tablet, HUAWEI, DMP, Operation (mathematics), Work, Petal, Advertising, Commerce, Omnichannel, Machine learning, Transport, Health, IOT, Medical tourism, Mobile phone, Retail, Huawei, AI

DUBAI, UAE, May 4, 2023 /PRNewswire/ -- Petal Ads, a leading advertising platform by Huawei, is participating in the 30th edition of Arabian Travel Market. The leading global event for the inbound and outbound travel industry in the Middle East will take place in Dubai on 1 to 4 May. Huawei's team of experts will demonstrate the unparalleled capabilities of Petal Ads, particularly in effectively targeting the rapidly growing outbound travel markets of China and Russia.

Key Points: 
  • DUBAI, UAE, May 4, 2023 /PRNewswire/ -- Petal Ads, a leading advertising platform by Huawei, is participating in the 30th edition of Arabian Travel Market.
  • Huawei's team of experts will demonstrate the unparalleled capabilities of Petal Ads, particularly in effectively targeting the rapidly growing outbound travel markets of China and Russia.
  • Also, with targeting and privacy, Marketers can feel sure that their ad spendings on targeting will deliver excellent dividends to them.
  • Visitors of the Arabian Travel Market, businesses and executives in the travel industry, as well as marketers, will have the unique opportunity to experience Petal Ads' sophisticated targeting capabilities firsthand, designed to unlock business potential.

IEEE-ISTO Announces Formation of the Inter Company Quality Analytics (IMPALA) Consortium

Retrieved on: 
Thursday, November 3, 2022
Good clinical practice, VP, Bristol Myers Squibb, IEEE, Board, Industry, Solution, Love, GLOBE, Biopharmaceutical, Merck Group, Consortium, Biogen, Knowledge, Certification, Johnson & Johnson, Friends, Merck & Co., Organization, Adoption, Quality assurance, Novartis, Risk, Dubai Health Authority, Roche, QA, Disease, Technology, IMPALA, Astellas Pharma, Patient, Program, Efficiency, Fine chemical, Pharmaceutical industry, Audit, Consumer electronics, Pfizer, Bayer

"Data and technology are at the forefront of every industry today, says Board Director Peter Alain, VP Head of Clinical Quality Assurance at Astellas.

Key Points: 
  • "Data and technology are at the forefront of every industry today, says Board Director Peter Alain, VP Head of Clinical Quality Assurance at Astellas.
  • We have a tremendous opportunity with the IMPALA Consortium to collaborate and incorporate advanced analytics capabilities to drive innovation and advancement of Quality Assurance across the pharmaceutical industry."
  • "One of the key advantages of the IMPALA consortium is the health authority engagement, adds Board Director Peter Alain.
  • IEEE-ISTO President Adam Newman states IEEE-ISTO welcomes the IMPALA Consortium as a new member program of IEEE-ISTO Federation of Programs.

Globee® Awards Announces Winners in the 2022 Business Excellence Awards

Retrieved on: 
Tuesday, October 11, 2022
Soma, SAN, HR, Migros, Globe Award, PricewaterhouseCoopers, Viettel, Intel, CEIS, Cement, ADP, OPET, CEO, Megaphone, Resolute Forest Products, GRIPS-Security and International Studies Program, Tokyo, LLC, Sheffield Business Awards, Cincinnati Children's Hospital Medical Center, Medidata Solutions, Industry, Information technology, Fiver, Public relations, RAK, Consultant, IBM, LastPass, Barilla, Gold, Customer success, International, ZER, Marketing, Los Robles Hospital & Medical Center, AIB, Employment, Origanum onites, Women's World Award, Panda Restaurant Group, TAC, Dubai Health Authority, Silver, Bright Machines, Flare, Epicor

SAN FRANCISCO, Oct. 11, 2022 /PRNewswire-PRWeb/ -- The Globee® Awards organizer of the world's premier business awards programs and business ranking lists has announced the Gold, Silver, and Bronze winners in the 12th Annual 2022 Business Excellence Awards.

Key Points: 
  • Globee Business Awards celebrate the achievements of employers, employees, and best business practices from all over the world.
  • SAN FRANCISCO, Oct. 11, 2022 /PRNewswire-PRWeb/ -- The Globee Awards organizer of the world's premier business awards programs and business ranking lists has announced the Gold, Silver, and Bronze winners in the 12th Annual 2022 Business Excellence Awards.
  • The coveted annual Business Excellence Awards is the world's premier awards program honoring the best employers, employees, and HR achievements.
  • Winners of one or more Gold Business Excellence Awards include BMW Northern Europe, TISK (Confederation of Employers' Unions of Turkey), LinkShadow, CEIS (Cement Industry Employers' Union), IKIO LED Lighting, Algoworks Technologies Pvt.

Roche Showcases Its Commitment to Advance Innovation In The Region at the Innovation Forum

Retrieved on: 
Wednesday, September 28, 2022
Culture, Roche, Roche Diagnostics, Agility, Dow Jones, Population, Industry, 125th, COVID, Mental health, Patient, CEO, Quality of life, Dubai Health Authority, General manager, United Arab Emirates, Method, Research, Ambassador, Pharma, DHA, Medical device, Fine chemical, Diagnosis

The forum brought together key stakeholders in the healthcare industry to share the latest research and build a robust and sustainable healthcare system.

Key Points: 
  • The forum brought together key stakeholders in the healthcare industry to share the latest research and build a robust and sustainable healthcare system.
  • The 2022 edition of the forum successfully registered the attendance of over 400 healthcare professionals, mainly medical laboratories and senior lab leaders from the region.
  • The experts explored together the advances in these areas and discussed how they affect and benefit patients and healthcare ecosystems.
  • As we enter a year of agility, resilience and transformation, our flagship innovation forum is a key platform where we aim to foster dialogues within the region.

Roche Showcases Its Commitment to Advance Innovation In The Region at the Innovation Forum

Retrieved on: 
Wednesday, September 28, 2022
Culture, Roche, Roche Diagnostics, Agility, Dow Jones, Population, Industry, 125th, COVID, Mental health, Patient, CEO, Quality of life, Dubai Health Authority, General manager, United Arab Emirates, Method, Research, Ambassador, Pharma, DHA, Multimedia, Medical device, Fine chemical, Diagnosis

The forum brought together key stakeholders in the healthcare industry to share the latest research and build a robust and sustainable healthcare system.

Key Points: 
  • The forum brought together key stakeholders in the healthcare industry to share the latest research and build a robust and sustainable healthcare system.
  • The 2022 edition of the forum successfully registered the attendance of over 400 healthcare professionals, mainly medical laboratories and senior lab leaders from the region.
  • The experts explored together the advances in these areas and discussed how they affect and benefit patients and healthcare ecosystems.
  • As we enter a year of agility, resilience and transformation, our flagship innovation forum is a key platform where we aim to foster dialogues within the region.

Roche Showcases Its Commitment to Advance Innovation In The Region at the Innovation Forum

Retrieved on: 
Wednesday, September 28, 2022
Culture, Roche, Roche Diagnostics, Agility, Dow Jones, Population, Industry, 125th, COVID, Mental health, Patient, CEO, Quality of life, Dubai Health Authority, General manager, United Arab Emirates, Method, Research, Ambassador, Pharma, DHA, Medical device, Fine chemical, Diagnosis

The forum brought together key stakeholders in the healthcare industry to share the latest research and build a robust and sustainable healthcare system.

Key Points: 
  • The forum brought together key stakeholders in the healthcare industry to share the latest research and build a robust and sustainable healthcare system.
  • The 2022 edition of the forum successfully registered the attendance of over 400 healthcare professionals, mainly medical laboratories and senior lab leaders from the region.
  • The experts explored together the advances in these areas and discussed how they affect and benefit patients and healthcare ecosystems.
  • As we enter a year of agility, resilience and transformation, our flagship innovation forum is a key platform where we aim to foster dialogues within the region.

Roche Showcases Its Commitment to Advance Innovation In The Region at the Innovation Forum

Retrieved on: 
Wednesday, September 28, 2022
Culture, Roche, Roche Diagnostics, Agility, Dow Jones, Population, Industry, 125th, COVID, Mental health, Patient, CEO, Quality of life, Dubai Health Authority, General manager, United Arab Emirates, Method, Research, Ambassador, Pharma, DHA, Multimedia, Medical device, Fine chemical, Diagnosis

The forum brought together key stakeholders in the healthcare industry to share the latest research and build a robust and sustainable healthcare system.

Key Points: 
  • The forum brought together key stakeholders in the healthcare industry to share the latest research and build a robust and sustainable healthcare system.
  • The 2022 edition of the forum successfully registered the attendance of over 400 healthcare professionals, mainly medical laboratories and senior lab leaders from the region.
  • The experts explored together the advances in these areas and discussed how they affect and benefit patients and healthcare ecosystems.
  • As we enter a year of agility, resilience and transformation, our flagship innovation forum is a key platform where we aim to foster dialogues within the region.